130 related articles for article (PubMed ID: 28967272)
1. Effects of psychosocial factors on monitoring treatment effect in newly diagnosed rheumatoid arthritis patients over time: response data from the tREACH study.
Kuijper TM; Luime JJ; Xiong H; de Jong P; van der Lubbe P; van Zeben D; Tchetverikov I; Hazes J; Weel A
Scand J Rheumatol; 2018 May; 47(3):178-184. PubMed ID: 28967272
[TBL] [Abstract][Full Text] [Related]
2. Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.
Allaart CF; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Breedveld FC; Dijkmans BA;
Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-77-82. PubMed ID: 17083767
[TBL] [Abstract][Full Text] [Related]
3. Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis.
Kekow J; Moots R; Khandker R; Melin J; Freundlich B; Singh A
Rheumatology (Oxford); 2011 Feb; 50(2):401-9. PubMed ID: 21059675
[TBL] [Abstract][Full Text] [Related]
4. Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial.
de Jong PH; Hazes JM; Han HK; Huisman M; van Zeben D; van der Lubbe PA; Gerards AH; van Schaeybroeck B; de Sonnaville PB; van Krugten MV; Luime JJ; Weel AE
Ann Rheum Dis; 2014 Jul; 73(7):1331-9. PubMed ID: 24788619
[TBL] [Abstract][Full Text] [Related]
5. Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial.
Matcham F; Norton S; Scott DL; Steer S; Hotopf M
Rheumatology (Oxford); 2016 Feb; 55(2):268-78. PubMed ID: 26350486
[TBL] [Abstract][Full Text] [Related]
6. Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial.
Kuijper TM; Luime JJ; de Jong PH; Gerards AH; van Zeben D; Tchetverikov I; de Sonnaville PB; van Krugten MV; Grillet BA; Hazes JM; Weel AE
Ann Rheum Dis; 2016 Dec; 75(12):2119-2123. PubMed ID: 27283332
[TBL] [Abstract][Full Text] [Related]
7. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study.
Michelsen B; Kristianslund EK; Sexton J; Hammer HB; Fagerli KM; Lie E; Wierød A; Kalstad S; Rødevand E; Krøll F; Haugeberg G; Kvien TK
Ann Rheum Dis; 2017 Nov; 76(11):1906-1910. PubMed ID: 28733473
[TBL] [Abstract][Full Text] [Related]
8. Sex-associated Treatment Differences and Their Outcomes in Rheumatoid Arthritis: Results from the METEOR Register.
Bergstra SA; Allaart CF; Ramiro S; Chopra A; Govind N; Silva C; Murphy EA; Landewé RBM
J Rheumatol; 2018 Oct; 45(10):1361-1366. PubMed ID: 29907672
[TBL] [Abstract][Full Text] [Related]
9. Response to glucocorticoids at 2 weeks predicts the effectiveness of DMARD induction therapy at 3 months: post hoc analyses from the tREACH study.
de Jong PH; Quax RA; Huisman M; Gerards AH; Feelders RA; de Sonnaville PB; Luime JJ; Weel AE; Hazes JM
Ann Rheum Dis; 2013 Oct; 72(10):1659-63. PubMed ID: 23117243
[TBL] [Abstract][Full Text] [Related]
10. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study.
Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Svendsen A; Pedersen JK; Skjødt H; Lauridsen UB; Ellingsen T; Hansen GV; Lindegaard H; Vestergaard A; Jurik AG; Østergaard M; Hørslev-Petersen K;
Ann Rheum Dis; 2008 Jun; 67(6):815-22. PubMed ID: 17878209
[TBL] [Abstract][Full Text] [Related]
11. Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study).
Heimans L; Akdemir G; Boer KV; Goekoop-Ruiterman YP; Molenaar ET; van Groenendael JH; Peeters AJ; Steup-Beekman GM; Lard LR; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
Arthritis Res Ther; 2016 Jan; 18():23. PubMed ID: 26794605
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.
Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van der Elst K; Westhovens R
Ann Rheum Dis; 2015 Jan; 74(1):27-34. PubMed ID: 25359382
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study.
Capell HA; Madhok R; Porter DR; Munro RA; McInnes IB; Hunter JA; Steven M; Zoma A; Morrison E; Sambrook M; Wui Poon F; Hampson R; McDonald F; Tierney A; Henderson N; Ford I
Ann Rheum Dis; 2007 Feb; 66(2):235-41. PubMed ID: 16926184
[TBL] [Abstract][Full Text] [Related]
14. Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.
Rannio T; Asikainen J; Hannonen P; Yli-Kerttula T; Ekman P; Pirilä L; Kuusalo L; Mali M; Puurtinen-Vilkki M; Kortelainen S; Paltta J; Taimen K; Kauppi M; Laiho K; Nyrhinen S; Mäkinen H; Isomäki P; Uotila T; Aaltonen K; Kautiainen H; Sokka T
Scand J Rheumatol; 2017 Nov; 46(6):425-431. PubMed ID: 28367663
[TBL] [Abstract][Full Text] [Related]
15. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
16. A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine.
Wojciechowski J; Wiese MD; Proudman SM; Foster DJ; Upton RN
Br J Clin Pharmacol; 2015 May; 79(5):777-88. PubMed ID: 25394211
[TBL] [Abstract][Full Text] [Related]
17. The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study.
Klarenbeek NB; Güler-Yüksel M; van der Kooij SM; Han KH; Ronday HK; Kerstens PJ; Seys PE; Huizinga TW; Dijkmans BA; Allaart CF
Ann Rheum Dis; 2011 Jun; 70(6):1039-46. PubMed ID: 21415052
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid arthritis patients with continued low disease activity have similar outcomes over 10 years, regardless of initial therapy.
Bergstra SA; Landewé RBM; Huizinga TWJ; Allaart CF
Rheumatology (Oxford); 2017 Oct; 56(10):1721-1728. PubMed ID: 28957556
[TBL] [Abstract][Full Text] [Related]
19. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.
Vermeer M; Kuper HH; Hoekstra M; Haagsma CJ; Posthumus MD; Brus HL; van Riel PL; van de Laar MA
Arthritis Rheum; 2011 Oct; 63(10):2865-72. PubMed ID: 21647867
[TBL] [Abstract][Full Text] [Related]
20. Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis.
van der Kooij SM; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Güler-Yüksel M; Zwinderman AH; Kerstens PJ; van der Lubbe PA; de Beus WM; Grillet BA; Ronday HK; Huizinga TW; Breedveld FC; Dijkmans BA; Allaart CF
Ann Rheum Dis; 2009 Jun; 68(6):914-21. PubMed ID: 18662933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
